Cargando…
An Endogenous Retrovirus Vaccine Encoding an Envelope with a Mutated Immunosuppressive Domain in Combination with Anti-PD1 Treatment Eradicates Established Tumours in Mice
Endogenous retroviruses (ERVs) account for 8% of our genome, and, although they are usually silent in healthy tissues, they become reactivated and expressed in pathological conditions such as cancer. Several studies support a functional role of ERVs in tumour development and progression, specificall...
Autores principales: | Daradoumis, Joana, Ragonnaud, Emeline, Skandorff, Isabella, Nielsen, Karen Nørgaard, Bermejo, Amaia Vergara, Andersson, Anne-Marie, Schroedel, Silke, Thirion, Christian, Neukirch, Lasse, Holst, Peter Johannes |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10141008/ https://www.ncbi.nlm.nih.gov/pubmed/37112906 http://dx.doi.org/10.3390/v15040926 |
Ejemplares similares
-
Cancer Associated Endogenous Retroviruses: Ideal Immune Targets for Adenovirus-Based Immunotherapy
por: Vergara Bermejo, Amaia, et al.
Publicado: (2020) -
Adenovirus based virus-like-vaccines targeting endogenous retroviruses can eliminate growing colorectal cancers in mice
por: Neukirch, Lasse, et al.
Publicado: (2019) -
Human Ad19a/64 HERV-W Vaccines Uncover Immunosuppression Domain-Dependent T-Cell Response Differences in Inbred Mice
por: Skandorff, Isabella, et al.
Publicado: (2023) -
Comment on: Endogenous retroviruses expressed in human tumours cannot be used as targets for anti-tumour vaccines
por: Bermejo, Amaia Vergara, et al.
Publicado: (2021) -
The Insertion of an Evolutionary Lost Four-Amino-Acid Cytoplasmic Tail Peptide into a Syncytin-1 Vaccine Increases T- and B-Cell Responses in Mice
por: Skandorff, Isabella, et al.
Publicado: (2023)